These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 62181)
61. Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure. Kanis JA; Ledingham JG; Oliver DO; Walton RJ; Nairn IM Br Med J; 1976 Apr; 1(6014):879. PubMed ID: 1260390 [No Abstract] [Full Text] [Related]
62. Effects of bromocriptine on sweat gland function during heat acclimatization. Kaufman FL; Mills DE; Hughson RL; Peake GT Horm Res; 1988; 29(1):31-8. PubMed ID: 3397041 [TBL] [Abstract][Full Text] [Related]
63. Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate. Hamilton JM; Flaks A; Saluja PG; Maguire S J Natl Cancer Inst; 1975 Jun; 54(6):1385-400. PubMed ID: 166190 [TBL] [Abstract][Full Text] [Related]
65. Effect of prolactin and bromocriptine on the population of prostate neuroendocrine cells from intact and cyproterone acetate-treated rats: stereological and immunohistochemical study. Ingelmo I; Gómez V; Martín R; Codesal J; Rodríguez R; Pozuelo JM; Santamaría L Anat Rec (Hoboken); 2007 Jul; 290(7):855-61. PubMed ID: 17541972 [TBL] [Abstract][Full Text] [Related]
66. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism. Felt V; Nedvdková J Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253 [TBL] [Abstract][Full Text] [Related]
67. [Activity of plasma renin and plasma aldosterone in terminal renal failure]. Vetter W; Záruba K; Armbruster H; Beckerhoff R; Reck G; Siegenthaler W Schweiz Med Wochenschr; 1974 Dec; 104(49):1799-801. PubMed ID: 4456599 [No Abstract] [Full Text] [Related]
68. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women. Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363 [TBL] [Abstract][Full Text] [Related]
69. Effect of hemodialysis on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in anephric man. Read VH; McCaa CS; Bower JD; McCaa RE J Clin Endocrinol Metab; 1973 Apr; 36(4):773-8. PubMed ID: 4686385 [No Abstract] [Full Text] [Related]
70. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)]. Schellekens LA; Roland R; Lequin RM Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514 [No Abstract] [Full Text] [Related]
71. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment. Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834 [TBL] [Abstract][Full Text] [Related]
72. Bromocriptine and gastric acid output. Cowan GO Lancet; 1977 Feb; 1(8008):425. PubMed ID: 65533 [No Abstract] [Full Text] [Related]
73. Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release. Cassady JM; Li GS; Spitzner EB; Floss HG; Clemens JA J Med Chem; 1974 Mar; 17(3):300-7. PubMed ID: 4811225 [No Abstract] [Full Text] [Related]
74. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis. Olgaard K; Hagen C; Madsen S; Hummer L Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447 [TBL] [Abstract][Full Text] [Related]
75. Inhibition of the plasma-aldosterone response to frusemide by bromocriptine. Edwards CR; Miall PA; Hanker JP; Thorner MO; Al-Dujaili EA; Besser GM Lancet; 1975 Nov; 2(7941):903-5. PubMed ID: 53377 [TBL] [Abstract][Full Text] [Related]